BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7838129)

  • 1. Mechanism of clofilium block of the human Kv1.5 delayed rectifier potassium channel.
    Malayev AA; Nelson DJ; Philipson LH
    Mol Pharmacol; 1995 Jan; 47(1):198-205. PubMed ID: 7838129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of mibefradil block of the human heart delayed rectifier hKv1.5.
    Perchenet L; Clément-Chomienne O
    J Pharmacol Exp Ther; 2000 Nov; 295(2):771-8. PubMed ID: 11046117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Block of the inactivating potassium channel by clofilium and hydroxylamine depends on the sequence of the pore region.
    Yool AJ
    Mol Pharmacol; 1994 Nov; 46(5):970-6. PubMed ID: 7969088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Block of heart potassium channels by clofilium and its tertiary analogs: relationship between drug structure and type of channel blocked.
    Arena JP; Kass RS
    Mol Pharmacol; 1988 Jul; 34(1):60-6. PubMed ID: 2455861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct mechanisms of block of Kv1.5 channels by tertiary and quaternary amine clofilium compounds.
    Steidl JV; Yool AJ
    Biophys J; 2001 Nov; 81(5):2606-13. PubMed ID: 11606274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LY 97241 accelerates the apparent rate of inactivation of transient outward K+ current: characterization of open channel block.
    Zhang ZH; Steinberg MI
    J Pharmacol Exp Ther; 1995 Jul; 274(1):249-57. PubMed ID: 7616405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine.
    Kim SE; Ahn HS; Choi BH; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
    J Pharmacol Exp Ther; 2007 May; 321(2):753-62. PubMed ID: 17312186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clofilium-induced block of delayed rectifier type K+ current in atrial tumor cells (AT-1 cells).
    Bhattacharyya ML; Sarker S; Mull KP; Debnam Q
    J Mol Cell Cardiol; 1997 Jan; 29(1):301-7. PubMed ID: 9040045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hEAG1 and hERG1 potassium channels by clofilium and its tertiary analogue LY97241.
    Gessner G; Heinemann SH
    Br J Pharmacol; 2003 Jan; 138(1):161-71. PubMed ID: 12522086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NH2-terminal inactivation peptide binding to C-type-inactivated Kv channels.
    Kurata HT; Wang Z; Fedida D
    J Gen Physiol; 2004 May; 123(5):505-20. PubMed ID: 15078918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural determinants of HERG channel block by clofilium and ibutilide.
    Perry M; de Groot MJ; Helliwell R; Leishman D; Tristani-Firouzi M; Sanguinetti MC; Mitcheson J
    Mol Pharmacol; 2004 Aug; 66(2):240-9. PubMed ID: 15266014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of potassium currents in rat ventricle by clofilium and its tertiary homolog.
    Castle NA
    J Pharmacol Exp Ther; 1991 Apr; 257(1):342-50. PubMed ID: 2019997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current.
    Lagrutta A; Wang J; Fermini B; Salata JJ
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1054-63. PubMed ID: 16522807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State-dependent block of rabbit vascular smooth muscle delayed rectifier and Kv1.5 channels by inhibitors of cytochrome P450-dependent enzymes.
    Iftinca M; Waldron GJ; Triggle CR; Cole WC
    J Pharmacol Exp Ther; 2001 Aug; 298(2):718-28. PubMed ID: 11454936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminopyridine block of Kv1.1 potassium channels expressed in mammalian cells and Xenopus oocytes.
    Castle NA; Fadous S; Logothetis DE; Wang GK
    Mol Pharmacol; 1994 Jun; 45(6):1242-52. PubMed ID: 8022416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of the delayed rectifier potassium current in porcine sino-atrial node cells.
    Ono K; Shibata S; Iijima T
    J Physiol; 2000 Apr; 524 Pt 1():51-62. PubMed ID: 10786611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
    Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X
    Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinidine preferentially blocks the slow delayed rectifier potassium channel in the rested state.
    Yao JA; Trybulski EJ; Tseng GN
    J Pharmacol Exp Ther; 1996 Nov; 279(2):856-64. PubMed ID: 8930193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human ether-a-go-go-related gene K+ channel and IKr of guinea pig cardiomyocytes by antipsychotic drug trifluoperazine.
    Choi SY; Koh YS; Jo SH
    J Pharmacol Exp Ther; 2005 May; 313(2):888-95. PubMed ID: 15722405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the cloned delayed rectifier K+ channels, Kv1.5 and Kv3.1, by riluzole.
    Ahn HS; Choi JS; Choi BH; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
    Neuroscience; 2005; 133(4):1007-19. PubMed ID: 15964489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.